The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oehen, S.
Right arrow Articles by Brduscha-Riem, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oehen, S.
Right arrow Articles by Brduscha-Riem, K.
The Journal of Immunology, 1998, 161: 5338-5346.
Copyright © 1998 by The American Association of Immunologists

Differentiation of Naive CTL to Effector and Memory CTL: Correlation of Effector Function with Phenotype and Cell Division1

Stephan Oehen2 and Karin Brduscha-Riem

Institute for Experimental Immunology, University Hospital Zürich, Zürich, Switzerland

Phenotypically and functionally, the early steps of T cell differentiation are not well characterized. In addition, the effector T cell stage shares several phenotypic characteristics with memory T cells, which has made the analysis of T cell memory difficult. In this study, we have investigated in vitro and in vivo the differentiation of naive CTL into effector and memory CTL as a function of cell division using lymphocytic choriomeningitis virus-specific TCR-transgenic spleen cells labeled with the vital dye carboxyfluorescein diacetate, succinimidyl ester. The following major points emerged. 1) During the first nine cell divisions, the investigated cell surface markers were strongly modulated. 2) The TCR was stepwise down-regulated during viral infection. 3) Cytotoxic effector function was acquired within one cell division and was retained during the next four to five divisions. 4) In vitro, CTL reached a CD44highCD62L+ memory phenotype after 6–10 cell divisions and required restimulation to exert effector function. 5) Lymphocytic choriomeningitis virus memory mice contained two distinct memory populations: a CD44highCD62L- population, predominately located in the spleen and exerting rapid effector function, and a CD44highCD62L+ population found in the spleen and the lymph nodes, which had lost immediate effector function. This finding suggests that two types of memory CTL exist. The correlation between CD62L expression, effector function, and Ag persistence is discussed.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. A. Broomfield, R. G. van der Most, A. C. Prosser, S. Mahendran, M. G. Tovey, M. J. Smyth, B. W. S. Robinson, and A. J. Currie
Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy
J. Immunol., May 1, 2009; 182(9): 5217 - 5224.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. D. Liu, T. Tomassian, K. W. Bruhn, J. F. Miller, F. Poirier, and M. C. Miceli
Galectin-1 Tunes TCR Binding and Signal Transduction to Regulate CD8 Burst Size
J. Immunol., May 1, 2009; 182(9): 5283 - 5295.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Brewig, A. Kissenpfennig, B. Malissen, A. Veit, T. Bickert, B. Fleischer, S. Mostbock, and U. Ritter
Priming of CD8+ and CD4+ T Cells in Experimental Leishmaniasis Is Initiated by Different Dendritic Cell Subtypes
J. Immunol., January 15, 2009; 182(2): 774 - 783.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. V. Ganusov and R. J. De Boer
Estimating In Vivo Death Rates of Targets due to CD8 T-Cell-Mediated Killing
J. Virol., December 1, 2008; 82(23): 11749 - 11757.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Sad, R. Dudani, K. Gurnani, M. Russell, H. van Faassen, B. Finlay, and L. Krishnan
Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells
J. Immunol., May 1, 2008; 180(9): 5853 - 5861.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Currie, R. G. van der Most, S. A. Broomfield, A. C. Prosser, M. G. Tovey, and B. W. S. Robinson
Targeting the Effector Site with IFN-{alpha}{beta}-Inducing TLR Ligands Reactivates Tumor-Resident CD8 T Cell Responses to Eradicate Established Solid Tumors
J. Immunol., February 1, 2008; 180(3): 1535 - 1544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Richards, M. P. Longhi, K. Wright, A. Gallimore, and A. Ager
CD62L (L-Selectin) Down-Regulation Does Not Affect Memory T Cell Distribution but Failure to Shed Compromises Anti-Viral Immunity
J. Immunol., January 1, 2008; 180(1): 198 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. Matthews, J. S. Qin, J. Yang, I. F. Hermans, M. J. Palmowski, V. Cerundolo, and F. Ronchese
Increasing the Survival of Dendritic Cells In Vivo Does Not Replace the Requirement for CD4+ T Cell Help during Primary CD8+ T Cell Responses
J. Immunol., November 1, 2007; 179(9): 5738 - 5747.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Jarchum, J. C. Baker, T. Yamada, T. Takaki, M. P. Marron, D. V. Serreze, and T. P. DiLorenzo
In Vivo Cytotoxicity of Insulin-Specific CD8+ T-Cells in HLA-A*0201 Transgenic NOD Mice
Diabetes, October 1, 2007; 56(10): 2551 - 2560.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. H. Horne, M. A. Koester, K. Jayashankar, K. E. Lunsford, H. L. Dziema, and G. L. Bumgardner
Disparate Primary and Secondary Allospecific CD8+ T Cell Cytolytic Effector Function in the Presence or Absence of Host CD4+ T Cells
J. Immunol., July 1, 2007; 179(1): 80 - 88.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R.-H. Xu, M. Fang, A. Klein-Szanto, and L. J. Sigal
Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection
PNAS, June 26, 2007; 104(26): 10992 - 10997.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. E. Knickelbein, S. Divito, and R. L. Hendricks
Modulation of CD8+ CTL Effector Function by Fibroblasts Derived from the Immunoprivileged Cornea
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2194 - 2202.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Chiu, A. G. Heaps, V. Cerundolo, A. J. McMichael, C. R. Bangham, and M. F. C. Callan
Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo
Blood, February 1, 2007; 109(3): 1086 - 1094.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Fang and L. J. Sigal
Direct CD28 Costimulation Is Required for CD8+ T Cell-Mediated Resistance to an Acute Viral Disease in a Natural Host
J. Immunol., December 1, 2006; 177(11): 8027 - 8036.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. A. Stoklasek, K. S. Schluns, and L. Lefrancois
Combined IL-15/IL-15R{alpha} Immunotherapy Maximizes IL-15 Activity In Vivo
J. Immunol., November 1, 2006; 177(9): 6072 - 6080.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-W. Lee, Y. Park, A. Song, H. Cheroutre, B. S. Kwon, and M. Croft
Functional Dichotomy between OX40 and 4-1BB in Modulating Effector CD8 T Cell Responses
J. Immunol., October 1, 2006; 177(7): 4464 - 4472.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Laffont, J. D. Coudert, L. Garidou, L. Delpy, A. Wiedemann, C. Demur, C. Coureau, and J.-C. Guery
CD8+ T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo
Blood, October 1, 2006; 108(7): 2257 - 2264.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Luu, K. Gurnani, R. Dudani, R. Kammara, H. van Faassen, J.-C. Sirard, L. Krishnan, and S. Sad
Delayed Expansion and Contraction of CD8+ T Cell Response during Infection with Virulent Salmonella typhimurium
J. Immunol., August 1, 2006; 177(3): 1516 - 1525.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Meng, H. Harlin, J. P. O'Keefe, and T. F. Gajewski
Induction of Cytotoxic Granules in Human Memory CD8+ T Cell Subsets Requires Cell Cycle Progression
J. Immunol., August 1, 2006; 177(3): 1981 - 1987.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Masopust, S.-J. Ha, V. Vezys, and R. Ahmed
Stimulation History Dictates Memory CD8 T Cell Phenotype: Implications for Prime-Boost Vaccination
J. Immunol., July 15, 2006; 177(2): 831 - 839.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Nishimura, J. E. Dusak, J. Eguchi, X. Zhu, A. Gambotto, W. J. Storkus, and H. Okada
Adoptive Transfer of Type 1 CTL Mediates Effective Anti-Central Nervous System Tumor Response: Critical Roles of IFN-Inducible Protein-10.
Cancer Res., April 15, 2006; 66(8): 4478 - 4487.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Every, D. R. Kramer, S. I. Mannering, A. M. Lew, and L. C. Harrison
Intranasal Vaccination with Proinsulin DNA Induces Regulatory CD4+ T Cells That Prevent Experimental Autoimmune Diabetes.
J. Immunol., April 15, 2006; 176(8): 4608 - 4615.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yang, S. P. Huck, R. S. McHugh, I. F. Hermans, and F. Ronchese
Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo
PNAS, January 3, 2006; 103(1): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. R. Haas, J. Sun, A. Vachani, A. F. Wallace, M. Silverberg, V. Kapoor, and S. M. Albelda
Cycloxygenase-2 Inhibition Augments the Efficacy of a Cancer Vaccine
Clin. Cancer Res., January 1, 2006; 12(1): 214 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. Lunsford, M. A. Koester, A. M. Eiring, P. H. Horne, D. Gao, and G. L. Bumgardner
Targeting LFA-1 and CD154 Suppresses the In Vivo Activation and Development of Cytolytic (CD4-Independent) CD8+ T Cells
J. Immunol., December 15, 2005; 175(12): 7855 - 7866.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. K. Ahn, H. Chung, D.-s. Lee, Y. S. Yu, and H. G. Yu
CD8brightCD56+ T Cells Are Cytotoxic Effectors in Patients with Active Behcet's Uveitis
J. Immunol., November 1, 2005; 175(9): 6133 - 6142.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Barouch-Bentov, E. E. Lemmens, J. Hu, E. M. Janssen, N. M. Droin, J. Song, S. P. Schoenberger, and A. Altman
Protein Kinase C-{theta} Is an Early Survival Factor Required for Differentiation of Effector CD8+ T Cells
J. Immunol., October 15, 2005; 175(8): 5126 - 5134.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Thimme, V. Appay, M. Koschella, E. Panther, E. Roth, A. D. Hislop, A. B. Rickinson, S. L. Rowland-Jones, H. E. Blum, and H. Pircher
Increased Expression of the NK Cell Receptor KLRG1 by Virus-Specific CD8 T Cells during Persistent Antigen Stimulation
J. Virol., September 15, 2005; 79(18): 12112 - 12116.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Parameswaran, R. Suresh, V. Bal, S. Rath, and A. George
Lack of ICAM-1 on APCs during T Cell Priming Leads to Poor Generation of Central Memory Cells
J. Immunol., August 15, 2005; 175(4): 2201 - 2211.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. van Faassen, M. Saldanha, D. Gilbertson, R. Dudani, L. Krishnan, and S. Sad
Reducing the Stimulation of CD8+ T Cells during Infection with Intracellular Bacteria Promotes Differentiation Primarily into a Central (CD62LhighCD44high) Subset
J. Immunol., May 1, 2005; 174(9): 5341 - 5350.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Chea, C. J. Dale, R. De Rose, I. A. Ramshaw, and S. J. Kent
Enhanced Cellular Immunity in Macaques following a Novel Peptide Immunotherapy
J. Virol., March 15, 2005; 79(6): 3748 - 3757.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Bouneaud, Z. Garcia, P. Kourilsky, and C. Pannetier
Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo
J. Exp. Med., February 22, 2005; 201(4): 579 - 590.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Ruedl, K. Schwarz, A. Jegerlehner, T. Storni, V. Manolova, and M. F. Bachmann
Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies
J. Virol., January 15, 2005; 79(2): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Prasad, K. J. Farrand, S. A. Matthews, J. H. Chang, R. S. McHugh, and F. Ronchese
Dendritic Cells Loaded with Stressed Tumor Cells Elicit Long-Lasting Protective Tumor Immunity in Mice Depleted of CD4+CD25+ Regulatory T Cells
J. Immunol., January 1, 2005; 174(1): 90 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Kassiotis and B. Stockinger
Anatomical Heterogeneity of Memory CD4+ T Cells Due to Reversible Adaptation to the Microenvironment
J. Immunol., December 15, 2004; 173(12): 7292 - 7298.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. B. Kamath, J. Woodworth, X. Xiong, C. Taylor, Y. Weng, and S. M. Behar
Cytolytic CD8+ T Cells Recognizing CFP10 Are Recruited to the Lung after Mycobacterium tuberculosis Infection
J. Exp. Med., December 6, 2004; 200(11): 1479 - 1489.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Junt, E. Scandella, R. Forster, P. Krebs, S. Krautwald, M. Lipp, H. Hengartner, and B. Ludewig
Impact of CCR7 on Priming and Distribution of Antiviral Effector and Memory CTL
J. Immunol., December 1, 2004; 173(11): 6684 - 6693.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Stumbles, R. Himbeck, J. A. Frelinger, E. J. Collins, R. A. Lake, and B. W. S. Robinson
Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation
J. Immunol., November 15, 2004; 173(10): 5923 - 5928.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Roychowdhury, K. F. May Jr., K. S. Tzou, T. Lin, D. Bhatt, A. G. Freud, M. Guimond, A. K. Ferketich, Y. Liu, and M. A. Caligiuri
Failed Adoptive Immunotherapy with Tumor-Specific T Cells: Reversal with Low-Dose Interleukin 15 but not Low-Dose Interleukin 2
Cancer Res., November 1, 2004; 64(21): 8062 - 8067.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Cannarile, N. Decanis, J. P. M. van Meerwijk, and T. Brocker
The Role of Dendritic Cells in Selection of Classical and Nonclassical CD8+ T Cells In Vivo
J. Immunol., October 15, 2004; 173(8): 4799 - 4805.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Quemeneur, L. Beloeil, M.-C. Michallet, G. Angelov, M. Tomkowiak, J.-P. Revillard, and J. Marvel
Restriction of De Novo Nucleotide Biosynthesis Interferes with Clonal Expansion and Differentiation into Effector and Memory CD8 T Cells
J. Immunol., October 15, 2004; 173(8): 4945 - 4952.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. E. Foster, M. Marangolo, M. M. Sartor, S. I. Alexander, M. Hu, K. F. Bradstock, and D. J. Gottlieb
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion
Blood, October 15, 2004; 104(8): 2403 - 2409.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Lustgarten, A. L. Dominguez, and M. Thoman
Aged Mice Develop Protective Antitumor Immune Responses with Appropriate Costimulation
J. Immunol., October 1, 2004; 173(7): 4510 - 4515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. D. Peacock and R. M. Welsh
Origin and Fate of Lymphocytic Choriomeningitis Virus-Specific CD8+ T Cells Coexpressing the Inhibitory NK Cell Receptor Ly49G2
J. Immunol., July 1, 2004; 173(1): 478 - 484.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wherry and R. Ahmed
Memory CD8 T-Cell Differentiation during Viral Infection
J. Virol., June 1, 2004; 78(11): 5535 - 5545.
[Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Lyman, S. Aung, J. A. Biggs, and L. A. Sherman
A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8+ T Lymphocytes into Effector CTL
J. Immunol., June 1, 2004; 172(11): 6558 - 6567.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. van Faassen, R. Dudani, L. Krishnan, and S. Sad
Prolonged Antigen Presentation, APC-, and CD8+ T Cell Turnover during Mycobacterial Infection: Comparison with Listeria monocytogenes
J. Immunol., March 15, 2004; 172(6): 3491 - 3500.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
U. Karrer, M. Wagner, S. Sierro, A. Oxenius, H. Hengel, T. Dumrese, S. Freigang, U. H. Koszinowski, R. E. Phillips, and P. Klenerman
Expansion of Protective CD8+ T-Cell Responses Driven by Recombinant Cytomegaloviruses
J. Virol., March 1, 2004; 78(5): 2255 - 2264.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Duraiswamy, M. Bharadwaj, J. Tellam, G. Connolly, L. Cooper, D. Moss, S. Thomson, P. Yotnda, and R. Khanna
Induction of Therapeutic T-Cell Responses to Subdominant Tumor-associated Viral Oncogene after Immunization with Replication-incompetent Polyepitope Adenovirus Vaccine
Cancer Res., February 15, 2004; 64(4): 1483 - 1489.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. S. Schluns, K. D. Klonowski, and L. Lefrancois
Transregulation of memory CD8 T-cell proliferation by IL-15R{alpha}+ bone marrow-derived cells
Blood, February 1, 2004; 103(3): 988 - 994.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Bellier, V. Thomas-Vaslin, M.-F. Saron, and D. Klatzmann
Turning immunological memory into amnesia by depletion of dividing T cells
PNAS, December 9, 2003; 100(25): 15017 - 15022.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Jackaman, C. S. Bundell, B. F. Kinnear, A. M. Smith, P. Filion, D. van Hagen, B. W. S. Robinson, and D. J. Nelson
IL-2 Intratumoral Immunotherapy Enhances CD8+ T Cells That Mediate Destruction of Tumor Cells and Tumor-Associated Vasculature: A Novel Mechanism for IL-2
J. Immunol., November 15, 2003; 171(10): 5051 - 5063.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Chapdelaine, D. K. Smith, J. A. Pedras-Vasconcelos, L. Krishnan, and S. Sad
Increased CD8+ T Cell Memory to Concurrent Infection at the Expense of Increased Erosion of Pre-existing Memory: The Paradoxical Role of IL-15
J. Immunol., November 15, 2003; 171(10): 5454 - 5460.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Lefrancois, A. Marzo, and K. Williams
Sustained Response Initiation Is Required for T Cell Clonal Expansion But Not for Effector or Memory Development In Vivo
J. Immunol., September 15, 2003; 171(6): 2832 - 2839.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Stamou, J. de Jersey, D. Carmignac, C. Mamalaki, D. Kioussis, and B. Stockinger
Chronic Exposure to Low Levels of Antigen in the Periphery Causes Reversible Functional Impairment Correlating with Changes in CD5 Levels in Monoclonal CD8 T Cells
J. Immunol., August 1, 2003; 171(3): 1278 - 1284.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Storni, C. Ruedl, W. A. Renner, and M. F. Bachmann
Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
J. Immunol., July 15, 2003; 171(2): 795 - 801.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Kimachi, K. Sugie, and H. M. Grey
Effector T cells have a lower ligand affinity threshold for activation than naive T cells
Int. Immunol., July 1, 2003; 15(7): 885 - 892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Camporeale, A. Boni, G. Iezzi, E. Degl'Innocenti, M. Grioni, A. Mondino, and M. Bellone
Critical Impact of the Kinetics of Dendritic Cells Activation on the in Vivo Induction of Tumor-specific T Lymphocytes
Cancer Res., July 1, 2003; 63(13): 3688 - 3694.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Byers, C. C. Kemball, J. M. Moser, and A. E. Lukacher
Cutting Edge: Rapid In Vivo CTL Activity by Polyoma Virus-Specific Effector and Memory CD8+ T Cells
J. Immunol., July 1, 2003; 171(1): 17 - 21.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. M. Curtsinger, D. C. Lins, and M. F. Mescher
Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function
J. Exp. Med., May 5, 2003; 197(9): 1141 - 1151.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Duraiswamy, M. Sherritt, S. Thomson, J. Tellam, L. Cooper, G. Connolly, M. Bharadwaj, and R. Khanna
Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma
Blood, April 15, 2003; 101(8): 3150 - 3156.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
V. Douin-Echinard, J.-M. Peron, V. Lauwers-Cances, G. Favre, and B. Couderc
Involvement of CD70 and CD80 intracytoplasmic domains in the co-stimulatory signal required to provide an antitumor immune response
Int. Immunol., March 1, 2003; 15(3): 359 - 372.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. V. Ravkov, C. M. Myrick, and J. D. Altman
Immediate Early Effector Functions of Virus-Specific CD8+CCR7+ Memory Cells in Humans Defined by HLA and CC Chemokine Ligand 19 Tetramers
J. Immunol., March 1, 2003; 170(5): 2461 - 2468.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Karrer, S. Sierro, M. Wagner, A. Oxenius, H. Hengel, U. H. Koszinowski, R. E. Phillips, and P. Klenerman
Memory Inflation: Continuous Accumulation of Antiviral CD8+ T Cells Over Time
J. Immunol., February 15, 2003; 170(4): 2022 - 2029.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. E. Hirst, M. S. Buzza, C. H. Bird, H. S. Warren, P. U. Cameron, M. Zhang, P. G. Ashton-Rickardt, and P. I. Bird
The Intracellular Granzyme B Inhibitor, Proteinase Inhibitor 9, Is Up-Regulated During Accessory Cell Maturation and Effector Cell Degranulation, and Its Overexpression Enhances CTL Potency
J. Immunol., January 15, 2003; 170(2): 805 - 815.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. L. Hengel, V. Thaker, M. V. Pavlick, J. A. Metcalf, G. Dennis Jr., J. Yang, R. A. Lempicki, I. Sereti, and H. C. Lane
Cutting Edge: L-Selectin (CD62L) Expression Distinguishes Small Resting Memory CD4+ T Cells That Preferentially Respond to Recall Antigen
J. Immunol., January 1, 2003; 170(1): 28 - 32.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
B. P. Olivieri, V. Cotta-de-Almeida, and T. Araujo-Jorge
Benznidazole Treatment following Acute Trypanosoma cruzi Infection Triggers CD8+ T-Cell Expansion and Promotes Resistance to Reinfection
Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3790 - 3796.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. E. Harmala, E. G. Ingulli, J. M. Curtsinger, M. M. Lucido, C. S. Schmidt, B. J. Weigel, B. R. Blazar, M. F. Mescher, and C. A. Pennell
The Adjuvant Effects of Mycobacterium tuberculosis Heat Shock Protein 70 Result from the Rapid and Prolonged Activation of Antigen-Specific CD8+ T Cells In Vivo
J. Immunol., November 15, 2002; 169(10): 5622 - 5629.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Hernandez, S. Aung, K. Marquardt, and L. A. Sherman
Uncoupling of Proliferative Potential and Gain of Effector Function by CD8+ T Cells Responding to Self-Antigens
J. Exp. Med., August 5, 2002; 196(3): 323 - 333.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Haglund, I. Leiner, K. Kerksiek, L. Buonocore, E. Pamer, and J. K. Rose
Robust Recall and Long-Term Memory T-Cell Responses Induced by Prime-Boost Regimens with Heterologous Live Viral Vectors Expressing Human Immunodeficiency Virus Type 1 Gag and Env Proteins
J. Virol., June 27, 2002; 76(15): 7506 - 7517.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. P. Li, Z. Cai, W. Shi, A. Brunmark, M. Jackson, and P.-J. Linton
Early Antigen-Specific Response by Naive CD8 T Cells Is Not Altered with Aging
J. Immunol., June 15, 2002; 168(12): 6120 - 6127.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. N. Mueller, C. M. Jones, C. M. Smith, W. R. Heath, and F. R. Carbone
Rapid Cytotoxic T Lymphocyte Activation Occurs in the Draining Lymph Nodes After Cutaneous Herpes Simplex Virus Infection as a Result of Early Antigen Presentation and Not the Presence of Virus
J. Exp. Med., March 4, 2002; 195(5): 651 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Coles, S. N. Mueller, W. R. Heath, F. R. Carbone, and A. G. Brooks
Progression of Armed CTL from Draining Lymph Node to Spleen Shortly After Localized Infection with Herpes Simplex Virus 1
J. Immunol., January 15, 2002; 168(2): 834 - 838.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. J. Estcourt, A. J. Ramsay, A. Brooks, S. A. Thomson, C. J. Medveckzy, and I. A. Ramshaw
Prime-boost immunization generates a high frequency, high-avidity CD8+ cytotoxic T lymphocyte population
Int. Immunol., January 1, 2002; 14(1): 31 - 37.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
W. Weninger, M. A. Crowley, N. Manjunath, and U. H. von Andrian
Migratory Properties of Naive, Effector, and Memory CD8+ T Cells
J. Exp. Med., October 1, 2001; 194(7): 953 - 966.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Sato, Y. Torimoto, Y. Tamura, M. Shindo, H. Shinzaki, K. Hirai, and Y. Kohgo
Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice
Blood, September 15, 2001; 98(6): 1852 - 1857.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Hernandez, S. Aung, W. L. Redmond, and L. A. Sherman
Phenotypic and Functional Analysis of CD8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-Antigen
J. Exp. Med., September 10, 2001; 194(6): 707 - 718.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. P. Medema, D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E.M. Toes, M. Toebes, T. N.M. Schumacher, et al.
Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte-induced Apoptosis: Differential Modulation by T Helper Type 1 and Type 2 Cells
J. Exp. Med., September 4, 2001; 194(5): 657 - 668.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Kudo, C A R Boyd, I L Sargent, and C W G Redman
Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation
J. Physiol., August 15, 2001; 535(1): 207 - 215.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. K. Sandberg, N. M. Fast, and D. F. Nixon
Functional Heterogeneity of Cytokines and Cytolytic Effector Molecules in Human CD8+ T Lymphocytes
J. Immunol., July 1, 2001; 167(1): 181 - 187.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Faint, N. E. Annels, S. J. Curnow, P. Shields, D. Pilling, A. D. Hislop, L. Wu, A. N. Akbar, C. D. Buckley, P. A. H. Moss, et al.
Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics
J. Immunol., July 1, 2001; 167(1): 212 - 220.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Auphan-Anezin and A.-M. Schmitt-Verhulst
Differential Survival of Transferred CD8 T Cells and Host Reconstitution Depending on TCR Avidity for Host-Expressed Alloantigen
J. Immunol., June 15, 2001; 166(12): 7200 - 7207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. J. Nelson, S. Mukherjee, C. Bundell, S. Fisher, D. van Hagen, and B. Robinson
Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective "Arming" of Tumor Antigen-Specific CTL
J. Immunol., May 1, 2001; 166(9): 5557 - 5566.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Hogan, E. J. Usherwood, W. Zhong, A. D. Roberts, R. W. Dutton, A. G. Harmsen, and D. L. Woodland
Activated Antigen-Specific CD8+ T Cells Persist in the Lungs Following Recovery from Respiratory Virus Infections
J. Immunol., February 1, 2001; 166(3): 1813 - 1822.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ahmadzadeh, S. F. Hussain, and D. L. Farber
Heterogeneity of the Memory CD4 T Cell Response: Persisting Effectors and Resting Memory T Cells
J. Immunol., January 15, 2001; 166(2): 926 - 935.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Izeradjene, J.-P. Revillard, and L. Genestier
Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells
Int. Immunol., January 1, 2001; 13(1): 85 - 93.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Yamada, G. Matsuzaki, Y. Iwamoto, and K. Nomoto
Unusual cytotoxic activities of thymus-independent, self-antigen-specific CD8+ T cells
Int. Immunol., December 1, 2000; 12(12): 1677 - 1683.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Marzo, B. F. Kinnear, R. A. Lake, J. J. Frelinger, E. J. Collins, B. W. S. Robinson, and B. Scott
Tumor-Specific CD4+ T Cells Have a Major ""Post-Licensing"" Role in CTL Mediated Anti-Tumor Immunity
J. Immunol., December 1, 2000; 165(11): 6047 - 6055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Nelson, C. Bundell, and B. Robinson
In Vivo Cross-Presentation of a Soluble Protein Antigen: Kinetics, Distribution, and Generation of Effector CTL Recognizing Dominant and Subdominant Epitopes
J. Immunol., December 1, 2000; 165(11): 6123 - 6132.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Apostolou, A. Cumano, G. Gachelin, and P. Kourilsky
Evidence for Two Subgroups of CD4-CD8- NKT Cells with Distinct TCR{alpha}{beta} Repertoires and Differential Distribution in Lymphoid Tissues
J. Immunol., September 1, 2000; 165(5): 2481 - 2490.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. K. Cho, V. P. Rao, Q. Ge, H. N. Eisen, and J. Chen
Homeostasis-stimulated Proliferation Drives Naive T Cells to Differentiate Directly into Memory T Cells
J. Exp. Med., August 21, 2000; 192(4): 549 - 556.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Murali-Krishna and R. Ahmed
Cutting Edge: Naive T Cells Masquerading as Memory Cells
J. Immunol., August 15, 2000; 165(4): 1733 - 1737.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Andersen, D. Dempsey, R. Chervenak, and S. R. Jennings
Expression of Intracellular IFN-{gamma} in HSV-1-Specific CD8+ T Cells Identifies Distinct Responding Subpopulations During the Primary Response to Infection
J. Immunol., August 15, 2000; 165(4): 2101 - 2107.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bousso, F. Lemaitre, J. Bilsborough, and P. Kourilsky
Facing Two T Cell Epitopes: A Degree of Randomness in the Primary Response Is Lost Upon Secondary Immunization
J. Immunol., July 15, 2000; 165(2): 760 - 767.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Gasser, P. Corthesy, F. Beerman, H. R. MacDonald, and M. Nabholz
Constitutive Expression of a Chimeric Receptor That Delivers IL-2/IL-15 Signals Allows Antigen-Independent Proliferation of CD8+CD44high But Not Other T Cells
J. Immunol., June 1, 2000; 164(11): 5659 - 5667.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. J. Dengler and J. S. Pober
Human Vascular Endothelial Cells Stimulate Memory But Not Naive CD8+ T Cells to Differentiate into CTL Retaining an Early Activation Phenotype
J. Immunol., May 15, 2000; 164(10): 5146 - 5155.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. Wodarz, R. M. May, and M. A. Nowak
The role of antigen-independent persistence of memory cytotoxic T lymphocytes
Int. Immunol., April 1, 2000; 12(4): 467 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. F. Hermans, D. S. Ritchie, J. Yang, J. M. Roberts, and F. Ronchese
CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity
J. Immunol., March 15, 2000; 164(6): 3095 - 3101.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.